Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Can Vaccine Development Be Safely Accelerated?

Pre-clinical immunization studies of iBio’s SARS-CoV-2 VLP candidates are being performed by Texas A&M.

iBio Advances COVID-19 Vaccine Development

Synairgen, a respiratory drug discovery and development company, has announced that it has received expedited approvals to conduct a trial of its inhaled formulation of interferon-beta-1a, SNG001, in COVID-19 patients.


UK Company Starts Trials of Inhaled Formulation for COVID-19

An NIH study of a COVID-19 vaccine is enrolling Seattle-based healthy adult volunteers.

NIH Begins Clinical Trial of Investigational Vaccine For COVID-19

Thermo Fisher Scientific launched the ALPS 5000 Plate Sealer to simplify the plate sealing process and provide enhanced dependability and productivity for stand-alone and integrated robotic projects. 

Compressor-Free Plate Sealer

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?

Fast vs. Formulated?

Agnes Shanley is senior editor of Pharmaceutical Technology.

Quick approval pathways challenge teams to balance compliance with the need for speed. 

Pre-Clinical: Laying the Right Foundation

Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.

Antibody Development Made Easier with Synthetic Biology

Mereo BioPharma Group and Oncologie have entered a global licensing agreement for the development and commercialization of navicixizumab.


Mereo BioPharma, Oncologie Form License Agreement for Ovarian Cancer Treatment

PhoreMost, a biopharma company based in the United Kingdom, and Boehringer Ingelheim have entered into a multi-project drug discovery collaboration agreement, it was revealed.


Early Phase Development